The provided source offers a detailed Wikipedia excerpt about Biogen Inc., an American multinational biotechnology company specializing in neurological diseases. The text furnishes comprehensive company information, including its founding in 1978, headquarters in Cambridge, Massachusetts, and financial data such as a 2024 revenue of US$9.676 billion. A significant portion of the article focuses on the company's history, acquisitions, and product portfolio, highlighting key drugs like those for multiple sclerosis and its controversial Alzheimer's treatment, Aducanumab (Aduhelm). Furthermore, the source details a lawsuit settlement regarding bribery allegations and notes a high-profile 2020 Biogen conference that became a major COVID-19 superspreading event.